A 20-year epidemiological study of pneumococcal meningitis

Clin Infect Dis. 1999 Jun;28(6):1265-72. doi: 10.1086/514777.

Abstract

We conducted a retrospective analysis of 55 community-acquired Streptococcus pneumoniae meningitis illnesses in Huntington, West Virginia, from 1978 to 1997. Fourteen (36.8%) of 38 adults and 2 (11.8%) of 17 children died. Serotypes 6, 23, 3, and 18 accounted for 20 (41.7%) of 48 strains available for serotyping. Of 40 strains available for antimicrobial susceptibility testing, 1 serotype 19 and 1 serotype 23 strain showed intermediate resistance and a second serotype 23 strain showed high resistance to penicillin; all three patients survived. The case-fatality rates among adults who received penicillin alone, gentamicin in combination, or vancomycin and cephalosporin together were 57.1%, 55.5%, and 60%, respectively, and among those who received chloramphenicol or a third-generation cephalosporin, they were 11.1% or nil, respectively. No child died who received chloramphenicol or vancomycin. Two (33%) of 6 children died who received a third-generation cephalosporin; both were critically ill when initially treated. No child and one adult had received pneumococcal vaccine prior to becoming ill.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Bacterial Vaccines / immunology
  • Cerebrospinal Fluid Proteins / analysis
  • Child
  • Child, Preschool
  • Humans
  • Incidence
  • Infant
  • Infant, Newborn
  • Meningitis, Pneumococcal / drug therapy
  • Meningitis, Pneumococcal / epidemiology*
  • Meningitis, Pneumococcal / mortality
  • Microbial Sensitivity Tests
  • Middle Aged
  • Pneumococcal Vaccines
  • Streptococcus pneumoniae / drug effects
  • Time Factors

Substances

  • Bacterial Vaccines
  • Cerebrospinal Fluid Proteins
  • Pneumococcal Vaccines